Characteristics of the Central Nervous System Malformations Presented in Trisomy 13: A single-center Experience in Recognizing the Phenotype and Genotype
Keywords:Trisomy 13, Central nervous system malformations, Cardiac malformations, Cardiopulmonary arrest, Severe infection
BACKGROUND: Patients who are diagnosed with trisomy 13 (Patau syndrome) are known to have a poor prognosis. It has been hypothesized that such poor outcomes are suspected to be attributed to their central nervous system (CNS)-malformations and cardiac-malformations. This study was conducted at Division of Neuropediatric, Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran – Dr. Hasan Sadikin Hospital, Bandung (2012–2018).
AIM: This study aimed to describe clinical characteristics and karyotype findings in patients who were diagnosed with Patau syndrome and treated at our center. Since Indonesia is still categorized as a lower middle-income country with limited resources, we expected that this study would provide a clinical reference on how a congenital disease with chromosomal abnormalities is confirmed.
CASE PRESENTATION: Our cases indicate that CNS malformations are likely to be the cause of indirect mortality of patients’ early period of life. The median survival in our study is 7 days, while the longest survival is 30 days. The major cause of death is apnea, which found in 4 of 5 diagnosed infants. One patient died of severe infection. In most cases, where CNS malformations were observed microcephaly with sloping forehead, Dandy–Walker syndrome, lobar or alobar holoprosencephaly and ventriculomegaly were identified, as well as neural tube defects (NTDs) were identified, such as spina bifida and meningoencephalocele. CNS malformations, such as holoprosencephaly, may be associated with episodes characterized by temporary cessation of spontaneous breathing (apnea) as direct cause of mortality.
CONCLUSION: We conclude that early treatment in Patau syndrome patient in our center should be focused on more life-threatening problem caused by CNS malformations than NTDs defects, such defects could be managed electively.
Plum Analytics Artifact Widget Block
Edwards JH, Harnden DG, Cameron AH, Crosse VM, Wolff OH. A new trisomic syndrome. Lancet. 1960;1(7128):787-90. https://doi.org/10.1016/s0140-6736(60)90675-9 PMid:13819419
Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history trisomy 13. Arch Dis Child. 1994;71(4):343-5. https://doi.org/10.1136/adc.71.4.343 PMid:7979530
Schinzel A. Catalogue of Unbalance Chromosome Aberration in Man. 2nd ed. Beril, New York: Walter de Gryter; 2001. p. 505-10.
Springett A, Wellesley D, Greenlees R, Loane M, Addor MC, Arriola L, et al. Congenital anomalies associated with trisomy 18 or trisomy 13: A registry-based study in 16 European countries, 2000-2011. Am J Med Genet A. 2015;167A(12):3062-9. https://doi.org/10.1002/ajmg.a.37355 PMid:26347425
Byrne J, Warburton D. Neural tube defects in spontaneous abortions. Am J Med Genet. 1986;25(2):327-33. https://doi.org/10.1002/ajmg.1320250219 PMid:3777029
Seller MJ. Neural tube defects, chromosome abnormalities and multiple closure sites for the human neural tube. Clin Dysmorphol. 1995;4(3):202-7. https://doi.org/10.1097/00019605-199507000-00002 PMid:7551155
Phadke SR, Thakur S. Prenatal diagnosis of iniencephaly and alobar holoprosen-cephaly with trisomy 13 mosaicism: A case report. Prenat Diagn. 2002;22(13):1240-1. https://doi.org/10.1002/pd.484 PMid:12478643
Halder A, Agarwal S, Pandey A. Iniencephaly and chromosome mosaicism: A report of two cases. Congenit Anom (Kyoto). 2005;45(3):102-5. https://doi.org/10.1111/j.1741-4520.2005.00076.x PMid:16131369
Rodriguez JI, Garcia M, Morales C, Morillo A, Delicado A. Trisomy 13 syndrome and neural tube defects. Am J Med Genet. 1990;36(4):513-6. https://doi.org/10.1002/ajmg.1320360429 PMid:2202219
Vendola C, Canfield M, Daiger SP, Gambello M, Hashmi SS, King T, et al. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet A. 2010;152A(2):360-6. https://doi.org/10.1002/ajmg.a.33156 PMid:20082470
Petry P, Polli JB, Mattos VF, Rosa RC, Zen PR, Graziadio C, et al. Clinical features and prognosis of a sample of patients with trisomy 13 (Patau syndrome) from Brazil. Am J Med Genet A. 2013;161A(6):1278-83. https://doi.org/10.1002/ajmg.a.35863 PMid:23613355
Peroos S, Forsythe E, Pugh JH, Arthur-Farraj P, Hodes D. Longevity and Patau syndrome: What determines survival? BMJ Case Rep. 2012;2012:bcr0620114381. https://doi.org/10.1136/bcr-06-2011-4381 PMid:23220825
Nelson KE, Rosella LC, Mahant S, Guttmann A. Survival and surgical interventions for children with trisomy 13 and 18. JAMA. 2016;316(4):420-8. https://doi.org/10.1001/jama.2016.9819 PMid:27458947
Kosho T, Nakamura T, Kawame H, Baba A, Tamura M, Fukushima Y. Neonatal management of trisomy 18: Clinical details of 24 patients receiving intensive treatment. Am J Med Genet A. 2006;140(9):937-44. https://doi.org/10.1002/ajmg.a.31175 PMid:16528744
Nelson KE, Hexem KR, Feudtner C. Inpatient hospital care of children with trisomy 13 and trisomy 18 in the United States. Pediatrics. 2012;129(5):869-76. https://doi.org/10.1542/peds.2011-2139 PMid:22492767
How to Cite
Copyright (c) 2020 Ahmad Faried, Bremmy Laksono, Danny Halim, Riksa Parikrama, Mirna Sobana, Muhammad Zafrullah Arifin (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
Grant numbers No. 16/E1/KPT/2020 (Basic Research)